3-mercaptopropionic acid has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Liang, CL; Liu, HJ; Liu, YR; Meng, J; Song, F; Sun, T; Wang, J; Xiao, T; Zhang, B; Zhang, CY; Zhang, Q; Zhou, HG | 1 |
1 other study(ies) available for 3-mercaptopropionic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes.
Topics: 3-Mercaptopropionic Acid; Animals; Blood Glucose; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hypoglycemic Agents; Insulin Resistance; Pancreas; Phenols; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Transcriptional Activation; Weight Gain; Zebrafish | 2015 |